Detalhe da pesquisa
1.
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.
Nature
; 590(7845): 320-325, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33260195
2.
A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
J Virol
; 96(16): e0075822, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924921
3.
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
Proc Natl Acad Sci U S A
; 117(43): 26955-26965, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037151
4.
The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution.
Cardiovasc Res
; 119(2): 520-535, 2023 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998078
5.
Use of Micro-Computed Tomography to Visualize and Quantify COVID-19 Vaccine Efficiency in Free-Breathing Hamsters.
Methods Mol Biol
; 2410: 177-192, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914047
6.
The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model.
Commun Biol
; 5(1): 225, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35273335
7.
MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.
Front Immunol
; 13: 845969, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35371064
8.
SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1α translocation in an animal model COVID-19.
Front Cardiovasc Med
; 9: 964512, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324747
9.
A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice.
JHEP Rep
; 3(4): 100295, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159304
10.
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.
Emerg Microbes Infect
; 10(1): 2279-2290, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792431
11.
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters.
EBioMedicine
; 68: 103403, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049240
12.
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.
Sci Transl Med
; 13(621): eabi7826, 2021 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34609205
13.
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial.
EBioMedicine
; 66: 103288, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33752127
14.
A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
Emerg Microbes Infect
; 9(1): 520-533, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32116148
15.
A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
mBio
; 11(2)2020 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32265332
16.
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.
Nat Commun
; 11(1): 5838, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203860
17.
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.
J Exp Med
; 216(9): 2057-2070, 2019 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31270247
18.
A yellow fever-Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice.
NPJ Vaccines
; 3: 56, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30564463
19.
Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens".
EBioMedicine
; 69: 103454, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34186486